Guideline for treating hepatitis B virus infection in Bangladesh

Authors

  • Salimur Rahman Department of Hepatology, Bangabandhu Sheikh Mujib Medical University
  • Mamun Al-Mahtab Department of Hepatology, Bangabandhu Sheikh Mujib Medical University
  • Md Fazal Karim Department of Hepatology, Dhaka Medical College

DOI:

https://doi.org/10.3329/blj.v1i1.2619

Keywords:

Hepatitis B

Abstract

Over 350 million people worldwide are infected with Hepatitis B virus (HBV) and globally around 1 million die due to consequences of this infection annually. Bangladesh belongs to the intermediate prevalence region for HBV infection. Here the lifetime risk of acquiring HBV is between 20-60%. Studies from our as well as other groups have shown that HBV is responsible for 31.25% cases of acute hepatitis, 76.3% cases of chronic hepatitis, 61.15% cases of cirrhosis of liver and 33.3% cases of hepatocellular carcinoma (HCC) in Bangladesh.  

doi: 10.3329/blj.v1i1.2619

Bangladesh Liver Journal Vol.1(1) 2009 p.6-12

 

Downloads

Download data is not yet available.
Abstract
8511
PDF
1792

Downloads

How to Cite

Rahman, S., Al-Mahtab, M., & Karim, M. F. (2009). Guideline for treating hepatitis B virus infection in Bangladesh. Bangladesh Liver Journal, 1(1), 6–12. https://doi.org/10.3329/blj.v1i1.2619

Issue

Section

Guidelines